Добірка наукової літератури з теми "Proteina TDP43"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Proteina TDP43".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Proteina TDP43"
Hill, Sarah J., Daniel A. Mordes, Lisa A. Cameron, Donna S. Neuberg, Serena Landini, Kevin Eggan, and David M. Livingston. "Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage." Proceedings of the National Academy of Sciences 113, no. 48 (November 14, 2016): E7701—E7709. http://dx.doi.org/10.1073/pnas.1611673113.
Повний текст джерелаLuo, Jiayi, and Paul M. Harrison. "Evolution of sequence traits of prion-like proteins linked to amyotrophic lateral sclerosis (ALS)." PeerJ 10 (November 17, 2022): e14417. http://dx.doi.org/10.7717/peerj.14417.
Повний текст джерелаLaudanski, Krzysztof, Jihane Hajj, Mariana Restrepo, Kumal Siddiq, Tony Okeke, and Daniel J. Rader. "Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early Strokes." Biomedicines 9, no. 12 (November 29, 2021): 1791. http://dx.doi.org/10.3390/biomedicines9121791.
Повний текст джерелаCarter, G. Campbell, Chia-Heng Hsiung, Leman Simpson, Haopeng Yang, and Xin Zhang. "N-terminal Domain of TDP43 Enhances Liquid-Liquid Phase Separation of Globular Proteins." Journal of Molecular Biology 433, no. 10 (May 2021): 166948. http://dx.doi.org/10.1016/j.jmb.2021.166948.
Повний текст джерелаRaghunathan, Rekha, Kathleen Turajane, and Li Chin Wong. "Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson’s Disease." International Journal of Molecular Sciences 23, no. 16 (August 18, 2022): 9299. http://dx.doi.org/10.3390/ijms23169299.
Повний текст джерелаTanaka, Hikari, and Hitoshi Okazawa. "PQBP1: The Key to Intellectual Disability, Neurodegenerative Diseases, and Innate Immunity." International Journal of Molecular Sciences 23, no. 11 (June 2, 2022): 6227. http://dx.doi.org/10.3390/ijms23116227.
Повний текст джерелаLee, Yichen, Bo H. Lee, William Yip, Pingchen Chou, and Bak-Sau Yip. "Neurofilament Proteins as Prognostic Biomarkers in Neurological Disorders." Current Pharmaceutical Design 25, no. 43 (January 9, 2020): 4560–69. http://dx.doi.org/10.2174/1381612825666191210154535.
Повний текст джерелаJiang, Tianlin, Jiahua Wang, Chao Li, Guiyun Cao, and Xiaohong Wang. "Prohibitins: A Key Link between Mitochondria and Nervous System Diseases." Oxidative Medicine and Cellular Longevity 2022 (July 8, 2022): 1–13. http://dx.doi.org/10.1155/2022/7494863.
Повний текст джерелаTang, Fu-Lei, Lu Zhao, Yang Zhao, Dong Sun, Xiao-Juan Zhu, Lin Mei, and Wen-Cheng Xiong. "Coupling of terminal differentiation deficit with neurodegenerative pathology in Vps35-deficient pyramidal neurons." Cell Death & Differentiation 27, no. 7 (January 6, 2020): 2099–116. http://dx.doi.org/10.1038/s41418-019-0487-2.
Повний текст джерелаMiguelez-Rodriguez, Aitzol, Jorge Santos-Juanes, Ikerne Vicente-Etxenausia, Katty Perez de Heredia-Goñi, Beatriz Garcia, Luis M. Quiros, Laura Lorente-Gea, Isabel Guerra-Merino, Jose J. Aguirre, and Ivan Fernandez-Vega. "Brains with sporadic Creutzfeldt-Jakob disease and copathology showed a prolonged end-stage of disease." Journal of Clinical Pathology 71, no. 5 (November 2, 2017): 446–50. http://dx.doi.org/10.1136/jclinpath-2017-204794.
Повний текст джерелаДисертації з теми "Proteina TDP43"
Fourier, Anthony. "Vers un marqueur biochimique des dégénérescences lobaires fronto-temporales : variations quantitatives et profils protéiques de la protéine TDP43 dans différentes matrices biologiques." Thesis, Lyon, 2018. http://www.theses.fr/2018LYSE1269/document.
Повний текст джерелаFrontotemporal lobar degeneration (FTLD) syndrome is the second most common of presenile dementia. FTLD is a clinically heterogeneous syndrome and comprises many hereditary cases. Common neuropathological features rely on a degeneration of the frontal and/or anterior temporal lobes, associated to specific inclusions of aggregated proteins including TAR DNA binding protein 43 (TDP43). Unfortunately, no practical protein marker is currently validated to improve FTLD diagnosis in living patients.A cohort of FTLD patients with definite TDP43 pathology was defined with the development of specific genetic testing. An analysis of TDP43 concentrations in cerebrospinal fluid (CSF) was performed in this cohort and then compared to other cohorts well-characterized on clinical and neuropathological features. Finally, qualitative patterns of TDP43 were studied in compartments accessible from the patient’s living: profiles of soluble TDP43 protein (in CSF or in plasma) and intracellular TDP43 protein (in the formed elements of blood) were compared to protein patterns observed in brain tissues with TDP43 protein inclusions. Platelet samples exhibit similar characteristics to brain tissue and could become a candidate biomarker for FTLD probabilistic diagnosis
Частини книг з теми "Proteina TDP43"
"TARDP (TDP43, Transcription of RNA activating protein/TAR DNA binding protein, human chromosome 1p36.2)." In Encyclopedia of Genetics, Genomics, Proteomics and Informatics, 1930. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6754-9_16677.
Повний текст джерелаТези доповідей конференцій з теми "Proteina TDP43"
Kim, Patrick Y., Owen Tan, Toby Trahair, Tao Liu, Glenn M. Marshall, and Belamy B. Cheung. "Abstract 1403: TRIM16 inhibits cell growth through direct interaction and modulation of TDP43 protein stability in cancer cells." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-1403.
Повний текст джерела